Sevoflurane post-conditioning increases nuclear factor erythroid 2-related factor and haemoxygenase-1 expression via protein kinase C pathway in a rat model of transient global cerebral ischaemia

British Journal of Anaesthesia

Volumn 114, Issue 2, 2015, Pages 307-318

  Lee, H ^a   Park, Y H ^b   Jeon, Y T ^c   Hwang, J W ^c   Lim, Y J ^c   Kim, E ^a   Park, S Y ^a   Park, H P ^a  

^a Seoul National University Hospital   (South Korea)

^b Chung Ang University   (South Korea)

^c Seoul National University Bundang Hospital   (South Korea)

Author keywords

anaesthetics; GA binding protein transcription factor; haeme oxygenase 1; inhalation; protein kinase C

Indexed keywords

CASPASE 3; CHELERYTHRINE; HEME OXYGENASE 1; PROTEIN KINASE C; SEVOFLURANE; TRANSCRIPTION FACTOR NRF2; ETHER DERIVATIVE; INHALATION ANESTHETIC AGENT; NFE2L2 PROTEIN, RAT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN ISCHEMIA; CONTROLLED STUDY; CYTOPLASM; ENZYME ACTIVATION; HISTOPATHOLOGY; ISCHEMIC POSTCONDITIONING; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REPERFUSION INJURY; SIGNAL TRANSDUCTION; ANIMAL; BIOSYNTHESIS; BRAIN; CONDITIONING; DRUG EFFECTS; ENZYMOLOGY; GENE EXPRESSION; METABOLISM; PATHOLOGY; PHYSIOLOGY; SPRAGUE DAWLEY RAT; TRANSIENT ISCHEMIC ATTACK;

ANESTHETICS, INHALATION; ANIMALS; BRAIN; CASPASE 3; CONDITIONING (PSYCHOLOGY); CYTOPLASM; GENE EXPRESSION; HEME OXYGENASE-1; ISCHEMIC ATTACK, TRANSIENT; METHYL ETHERS; NF-E2-RELATED FACTOR 2; PROTEIN KINASE C; RATS; RATS, SPRAGUE-DAWLEY; SIGNAL TRANSDUCTION;

EID: 84922565684     PISSN: 00070912     EISSN: 14716771     Source Type: Journal    
DOI: 10.1093/bja/aeu268     Document Type: Article

References (52)

1. Huang HC, Nguyen T, Pickett CB. Regulation of the antioxidant response element by protein kinase C-mediated phosphorylation of NF-E2-related factor 2. Proc Natl Acad Sci USA 2000; 97: 12475-80
2. de Ruijter W, Musters RJ, Boer C, Stienen GJ, Simonides WS, de Lange JJ. The cardioprotective effect of sevoflurane depends on protein kinase C activation, opening of mitochondrial K(+)(ATP) channels, and the production of reactive oxygen species. Anesth Analg 2003; 97: 1370-6
3. Liu HG, Hua Z, Zhang Y, et al. Effect of Sevoflurane postconditioning on gene expression in brain tissue of the middle cerebral artery occlusion rat model. Mol Biol Rep 2012; 39: 10505-13
4. Ye Z, Guo Q, Xia P, Wang N, Wang E, Yuan Y. Sevoflurane postconditioning involvesan up-regulation of HIF-1aandHO-1expression via PI3 K/Akt pathway in a rat model of focal cerebral ischemia. Brain Res 2012; 1463: 63-74
5. Kensler TW, Wakabayashi N, Biswal S. Cell survival responses to environmental stresses via the Keap1-Nrf2-ARE pathway. Annu Rev Pharmacol Toxicol 2007; 47: 89-116
6. Harvey CJ, Thimmulappa RK, Singh A, et al. Nrf2-regulated glutathione recycling independent of biosynthesis is critical for cell survival during oxidative stress. Free Radic Biol Med 2009; 46: 443-53
7. Mitsuishi Y, Motohashi H, Yamamoto M. The Keap1-Nrf2 system in cancers: stress response and anabolic metabolism. Front Oncol 2012; 2: 200
8. de Vries D, Kortekaas K, Tsikas D, et al. Oxidative damage in clinical ischemia/reperfusion injury: a reappraisal. Antioxid Redox Signal 2013; 19: 535-45
9. Ruiz S, Pergola PE, Zager RA, Vaziri ND. Targeting the transcription factor Nrf2 to ameliorate oxidative stress and inflammation in chronic kidney disease. Kidney Int 2013; 83: 1029-41
10. Meng H, Guo J, Wang H, Yan P, Niu X, Zhang J. Erythropoietin activates Keap1-Nrf2/ARE pathway in rat brain after ischemia. Int J Neurosci 2014; 124: 362-8
11. Li L, Zhang X, Cui L, et al. Ursolic acid promotes the neuroprotection by activating Nrf2 pathway after cerebral ischemia in mice. Brain Res 2013; 1497: 32-9
12. Niture SK, Jain AK, Jaiswal AK. Antioxidant-induced modification of INrf2 cysteine 151 and PKC-delta-mediated phosphorylation of Nrf2 serine 40 are both required for stabilization and nuclear translocation of Nrf2 and increased drug resistance. J Cell Sci 2009; 122: 4452-64
13. Uchida S, Fujiki M, Nagai Y, Abe T, Kobayashi H. Geranylgeranylacetone, a noninvasive heat shock protein inducer, induces protein kinase C and leads to neuroprotection against cerebral infarction in rats. Neurosci Lett 2006; 396: 220-4
14. Gustafsson LL, EblingWF, Osaki E, Stanski DR. Quantitation of depth of thiopental anesthesia in the rat. Anesthesiology 1996; 84: 415-27
15. Smith ML, Bendek G, Dahlgren N, Rosén I, Wieloch T, Siesjö BK. Models for studying long-term recovery following forebrain ischemia in the rat. 2. A 2-vessel occlusion model. Acta Neurol Scand 1984; 69: 385-401
16. Katz L, Ebmeyer U, Safar P, Radovsky A, Neumar R. Outcome model of asphyxial cardiac arrest in rats. J Cereb Blood Flow Metab 1995; 15: 1032-9
17. Zhang X, Xiao Z, Yao J, Zhao G, Fa X, Niu J. Participation of protein kinase C in the activation of Nrf2 signaling by ischemic preconditioning in the isolated rabbit heart. Mol Cell Biochem 2013; 372: 169-79
18. Espada S, Rojo AI, Salinas M, Cuadrado A. The muscarinic M1 receptor activates Nrf2 through a signaling cascade that involves protein kinase C and inhibition of GSK-3beta: connecting neurotransmission with neuroprotection. J Neurochem 2009; 110: 1107-19
19. Quesada A, Ogi J, Schultz J, Handforth A. C-terminal mechanogrowth factor induces heme oxygenase-1-mediated neuroprotection of SH-SY5Y cells via the protein kinase C/Nrf2 pathway. J Neurosci Res 2011; 89: 394-405
20. Zhang YC, Gan FF, Shelar SB, Ng KY, Chew EH. Antioxidant and Nrf2 inducing activities of luteolin, a flavonoid constituent in Ixeris sonchifolia Hance, provide neuroprotective effects against ischemiainduced cellular injury. Food Chem Toxicol 2013; 59: 272-80
21. Tulsulkar J, Shah ZA. Ginkgo biloba prevents transient global ischemia-induced delayed hippocampal neuronal death through antioxidant and anti-inflammatory mechanism. Neurochem Int 2013; 62: 189-97
22. Bell KF, Al-Mubarak B, Fowler JH, et al. Mild oxidative stress activates Nrf2 in astrocytes, which contributes to neuroprotective ischemic preconditioning. Proc Natl Acad Sci USA 2011; 108: E1-2
23. Jeon YT, HwangJW, Lim YJ, Kim AN, Park HP.Acombination of sevoflurane postconditioning and albumin increases bcl-2 expression after transient global cerebral ischemiacompared with either sevoflurane postconditioning or albumin alone. J Neurosurg Anesthesiol 2013; 25: 43-50
24. Adamczyk S, Robin E, Simerabet M, et al. Sevoflurane pre- and postconditioning protect the brain via the mitochondrial K ATP channel. Br J Anaesth 2010; 104: 191-200
25. Seo JH, ParkHP, Jeon YT, Lim YJ, NamK, Hwang JW. Combinedtreatment with celecoxib and sevoflurane after global cerebral ischaemia has no additive neuroprotective effects in rats. Br J Anaesth 2013; 110: 988-95
26. Wang JK, Yu LN, Zhang FJ, et al. Postconditioning with sevoflurane protects against focal cerebral ischemia and reperfusion injury via PI3 K/Akt pathway. Brain Res 2010; 1357: 142-51
27. Li D, Huang B, Liu J, Li L, Li X. Decreased brain K(ATP) channel contributes to exacerbating ischemic brain injury and the failure of neuroprotection by sevoflurane post-conditioning in diabetic rats. PLoS One 2013; 8: e73334
28. Ye Z, GuoQ, WangN, Xia P, Yuan Y, Wang E. Delayed neuroprotection induced by sevoflurane via opening mitochondrial ATP-sensitive potassium channels and p38 MAPK phosphorylation. Neurol Sci 2012; 33: 239-49
29. Toner CC, Connelly K, Whelpton R, et al. Effects of sevoflurane on dopamine, glutamate and aspartate release in an in vitro model of cerebral ischaemia. Br J Anaesth 2001; 86: 550-4
30. Ye R, Yang Q, Kong X, et al. Sevoflurane preconditioning improves mitochondrial function and long-term neurologic sequelae after transient cerebral ischemia: role of mitochondrial permeability transition. Crit Care Med 2012; 40: 2685-93
31. Tong L, CaiM, Huang Y, et al. Activation of K2P channel-TREK1 mediates the neuroprotection induced by sevoflurane preconditioning. Br J Anaesth 2014; 113: 157-67
32. Zhang D, Chiu KM, WangW, Sun D. Effects of conditioning with sevofluranebeforereperfusiononhippocampalischemicinjuryandinsulinlike growth factor-1 expression in rats. Chin J Physiol 2013; 56: 236-42
33. Rada P, Rojo AL, Chowdhry S, McMahon M, Hayes JD, Cuadrado A. SCF/{beta}-TrCP promotes glycogen synthase kinase 3-dependent degradation of the Nrf2 transcription factor in a Keap1-independent manner. Mol Cell Biol 2011; 31: 1121-33
34. Nguyen T, Sherratt PJ, Pickett CB. Regulatory mechanisms controlling gene expression mediated by the antioxidant response element. Annu Rev Pharmacol Toxicol 2003; 43: 233-60
35. Ma Q, He X. Molecular basis of electrophilic and oxidative defense: promises and perils of Nrf2. Pharmacol Rev 2012; 64: 1055-81
36. Willis CL, Meske DS, Davis TP. Protein kinase C activation modulates reversible increase in cortical blood-brain barrier permeability and tight junction protein expression during hypoxia and posthypoxic reoxygenation. J Cereb Blood Flow Metab 2010; 30: 1847-59
37. Dwivedi S, Nagarajan R, Hanif K, Siddiqui HH, Nath C, Shukla R. Standardized extract of Bacopa monniera attenuates okadaic acid induced memory dysfunction in rats: effect on Nrf2 pathway. Evid Based Complement Alternat Med 2013; 2013: 294501
38. Niture SK, Jaiswal AK. Nrf2 protein up-regulates antiapoptotic protein Bcl-2 and prevents cellular apoptosis. J Biol Chem 2012; 287: 9873-86
39. Niture SK, Jaiswal AK. Nrf2-induced antiapoptotic Bcl-xL protein enhances cell survival and drug resistance. Free Radic Biol Med 2013; 57: 119-31
40. Tusi SK, Ansari N, Amini M, Amirabad AD, Shafiee A, Khodagholi F. Attenuation of NF-kappaB and activation of Nrf2 signaling by 1, 2, 4-triazine derivatives, protects neuron-like PC12 cells against apoptosis. Apoptosis 2010; 15: 738-51
41. Jin W, Wang H, Yan W, et al. Role of Nrf2 in protection against traumatic brain injury in mice. J Neurotrauma 2009; 26: 131-9
42. Wang Q, Li X, Chen Y, et al. Activation of epsilon protein kinase C-mediated anti-apoptosis is involved in rapid tolerance induced by electroacupuncture pretreatment through cannabinoid receptor type 1. Stroke 2011; 42: 389-96
43. Liu H, McPherson BC, Yao Z. Preconditioning attenuates apoptosis and necrosis: role of protein kinase C epsilon and -delta isoforms. Am J Physiol Heart Circ Physiol 2001; 281: H404-10
44. Okamura T, Miura T, Iwamoto H, et al. Ischemic preconditioning attenuates apoptosis through protein kinase C in rat hearts. Am J Physiol 1999; 277: H1997-2001
45. Srivastava S, Alfieri A, Siow RC, Mann GE, Fraser PA. Temporal and spatial distribution of Nrf2 in rat brain following stroke: quantification of nuclear to cytoplasmic Nrf2 content using a novel immunohistochemical technique. J Physiol 2013; 591: 3525-38
46. Shokeir AA, Hussein AM, Barakat N, Abdelaziz A, Elgarba M, Awadalla A. Activation of nuclear factor erythroid 2-related factor 2 (Nrf2) and Nrf-2-dependent genes by ischaemic pre-conditioning and post-conditioning: new adaptive endogenous protective responses against renal ischaemia/reperfusion injury. Acta Physiol (Oxf) 2013; 210: 342-53
47. Bright R, Sun GH, Yenari MA, Steinberg GK, Mochly-Rosen D. epsilonPKC confers acute tolerance to cerebral ischemic reperfusion injury. Neurosci Lett 2008; 441: 120-4
48. Ye Z, Huang YM, Wang E, Zuo ZY, Guo QL. Sevoflurane-induced delayed neuroprotection involves mitoK(ATP) channel opening and PKC 1 activation. Mol Biol Rep 2012; 39: 5049-57
49. Wang Q, Zhang X, Ding Q, et al. Limb remote postconditioning alleviates cerebral reperfusion injury through reactive oxygen speciesmediated inhibition of delta protein kinase C in rats. Anesth Analg 2011; 113: 1180-7
50. Bright R, Mochly-Rosen D. The role of protein kinase C in cerebral ischemic and reperfusion injury. Stroke 2005; 36: 2781-90
51. Bouwman RA, Musters RJ, van Beek-Harmsen BJ, et al. Sevoflurane- induced cardioprotection depends on PKC-alpha activation via production of reactive oxygen species. Br J Anaesth 2007; 99: 639-45
52. Zhou C, Li H, Yao Y, Li L. Delayed remote ischemic preconditioning produces an additive cardioprotection to sevoflurane postconditioning through an enhanced heme oxygenase 1 level partly via nuclear factor erythroid 2-related factor 2 nuclear translocation. J Cardiovasc Pharmacol Ther Advance Access published on March 19, 2014, doi: 10.1177/1074248414524479